Decision aids are important tools in ensuring patients understand the medical choices they face. Our decision aid "Is a PSA Test Right for You?", takes a look at the same medical evidence that the U.S. Preventive Services Task Force (USPSTF) recently reviewed, and highlights what the evidence tells us about the PSA test's benefits- which are uncertain or limited for many men- and the harms of treatment if a screening results in a prostate cancer diagnosis.
Nine out of 10 Medicare patients who received a stent procedure for coronary disease report that their physicians did not present them with the non-invasive alternative of managing their condition with medication, according to the results of a study published online today by the Journal of General Internal Medicine. Floyd J. Fowler Jr., senior scientific advisor at the Informed Medical Decisions Foundation, was the study's principal investigator.
Posted in Current News
Tagged coronary artery disease, coronary artery disease treatment, decision support, heart disease, patient-centered care, patients, prostate cancer, prostate cancer treatment, prostate surgery, shared decision making, stenting, stents
Who should decide about screening for prostate cancer: expert panels of clinicians and methodologists, primary care clinicians, specialists, or fully informed patients themselves? The U.S. Preventive Services Task Force recently released a draft recommendation on screening for prostate cancer, designed for primary care physicians and health systems, and has opened if for public comment until November 8, 2011.
Here, we propose to fill this important knowledge gap regarding recent trends in both the evidence in prostate cancer and the role of shared decision-making tools in specialty practice that will form the basis for future shared decision-making implementation research.
The objectives are to 1) Survey mobile use around health issues in men newly eligible for prostate cancer screening, and 2) to develop a mobile PSA decision aid prototype based on the previously validated internet-based Prosdex decision support intervention (DESI) in preparation for subsequent field testing.
Dartmouth-Hitchcock Medical Center (DHMC) is comprised of physicians, specialists and other providers working together at different locations to meet the health care needs of patients in northern New England. The Center for Shared Decision Making (CSDM) at DHMC, opened its doors in 1999 as the first center in the U.S. to be dedicated to shared decision making, and became a Foundation funded primary and specialty care demonstration site at that time. True pioneers in the shared decision making arena, DHMC continues to perfect the process of providing access to decision aids and decision support to patients as a routine process of care.
A PSA test is often recommended for men over 50 and is one of America's most common screening tests. To help men consider the pros and cons of prostate cancer screening, the Foundation has developed a Shared Decision-Making® program called Is a PSA Test Right for You?
Prostate cancer progresses at different rates for different men. Therefore the best time to start hormone therapy is not the same for everyone. To help men decide if and when hormone therapy is right for them, the Informed Medical Decisions Foundation has developed a Shared Decision-Making® program called Hormone Therapy: When the PSA Rises after Prostate Cancer Treatment.